Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 1, 2025 | (Q2)Aug 2, 2025 | (Q1)May 3, 2025 | (FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.44%-782K | 58.54%-949K | -62.95%-13.41M | -16.44%32.33M | -1.15%43.68M | -119.95%-827K | -101.85%-2.29M | 3.21%-8.23M | 38.7M | 44.19M |
| Net income from continuing operations | -4.52%2.28M | 16.08%-4.39M | 11.06%-7.91M | -1,917.55%-33.44M | -248.43%-21.7M | 360.50%2.39M | 1.84%-5.24M | -11.66%-8.9M | --1.84M | --14.62M |
| Depreciation and amortization | -3.99%7.02M | -3.70%7.03M | -5.19%6.87M | -0.15%29.66M | 4.60%7.8M | -0.57%7.32M | -0.67%7.3M | -3.93%7.24M | --29.71M | --7.46M |
| Asset impairment expenditure | ---- | ---- | ---- | 81,867.21%50M | ---- | ---- | ---- | ---- | --61K | ---- |
| Remuneration paid in stock | --195K | 341.30%203K | -17.58%75K | -65.64%156K | -84.43%19K | --0 | -65.41%46K | -9.00%91K | --454K | --122K |
| Deferred tax | 4.60%909K | 19.45%-1.5M | 9.38%-2.82M | -1,543.80%-11.77M | -245.85%-7.66M | 235.52%869K | 0.00%-1.87M | -10.08%-3.11M | --815K | --5.25M |
| Other non cashItems | 7.79%2.06M | -4.23%1.99M | -5.27%2.02M | 15.75%8.27M | 1,720.34%2.15M | -25.04%1.91M | -5.62%2.08M | -6.26%2.13M | --7.14M | --118K |
| Change In working capital | -1.29%-11.19M | 9.69%-2.3M | -163.73%-9.66M | -163.69%-4.29M | -31.99%12.97M | -162.86%-11.05M | -76.52%-2.55M | 45.17%-3.66M | --6.74M | --19.07M |
| -Change in receivables | 82.79%-700K | 35.11%-2.12M | 44.43%2.67M | -1,379.23%-5.77M | -2.87%-287K | -447.10%-4.07M | 21.56%-3.26M | -35.72%1.85M | ---390K | ---279K |
| -Change in inventory | -1.70%-16.68M | -9.49%-9.38M | -37.24%477K | -125.68%-4.84M | -23.18%19.38M | -197.57%-16.4M | -57.35%-8.57M | -83.36%760K | --18.83M | --25.22M |
| -Change in prepaid assets | -120.41%-150K | 179.64%769K | -106.82%-2.85M | 202.84%1.96M | 793.73%2.32M | 473.10%735K | 154.63%275K | 6.77%-1.38M | ---1.9M | ---335K |
| -Change in payables and accrued expense | -27.40%6.33M | -6.06%8.69M | -109.76%-9.73M | 148.99%4.44M | -55.28%-8.89M | 1,751.38%8.72M | 8.28%9.25M | 62.39%-4.64M | ---9.05M | ---5.73M |
| -Change in other working capital | 130.30%10K | -8.44%-257K | 10.55%-229K | 89.57%-78K | 140.86%448K | 75.91%-33K | 51.13%-237K | 17.95%-256K | ---748K | --186K |
| Interest paid (cash flow from operating activities) | 13.18%-1.96M | 9.12%-1.87M | 6.16%-1.89M | 7.02%-8.36M | 9.09%-2.02M | 7.18%-2.26M | 5.80%-2.06M | 5.94%-2.01M | ---8.99M | ---2.22M |
| Tax refund paid | -1,583.33%-101K | -1,980.00%-104K | -1,128.57%-86K | 128.31%2.11M | 832.07%2.12M | -200.00%-6K | -150.00%-5K | -100.58%-7K | --922K | ---290K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.44%-782K | 58.54%-949K | -62.95%-13.41M | -16.44%32.33M | -1.15%43.68M | -119.95%-827K | -101.85%-2.29M | 3.21%-8.23M | --38.7M | --44.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 36.90%-1.05M | 16.21%-1.5M | -10.11%-2.06M | -30.56%-6.7M | 8.36%-1.38M | -79.31%-1.66M | -41.31%-1.79M | -30.43%-1.87M | -5.13M | -1.51M |
| Net PPE purchase and sale | 36.98%-1.05M | 15.18%-1.49M | -9.63%-2.05M | -39.06%-6.67M | 5.80%-1.38M | -79.20%-1.66M | -38.39%-1.75M | -64.96%-1.87M | ---4.79M | ---1.47M |
| Net intangibles purchas and sale | -100.00%-2K | 64.86%-13K | ---9K | 7.32%-38K | --0 | ---1K | ---37K | --0 | ---41K | ---41K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---300K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 36.90%-1.05M | 16.21%-1.5M | -10.11%-2.06M | -30.56%-6.7M | 8.36%-1.38M | -79.31%-1.66M | -41.31%-1.79M | -30.43%-1.87M | ---5.13M | ---1.51M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 92.85%10.54M | 22.35%-4.65M | -128.98%-12.64M | 47.55%-19.64M | 29.26%-13.61M | 270.20%5.47M | 14.46%-5.98M | 31.12%-5.52M | -37.45M | -19.23M |
| Net issuance payments of debt | 117.15%11.87M | 51.79%-2.84M | -123.63%-12.34M | 39.28%-19.82M | 27.83%-13.88M | 282.96%5.47M | -35.94%-5.88M | 9.33%-5.52M | ---32.63M | ---19.23M |
| Net common stock issuance | ---1.33M | ---1.54M | ---295K | 106.77%274K | --274K | --0 | --0 | --0 | ---4.05M | --0 |
| Net other financing activities | --0 | ---- | ---- | 86.98%-100K | --0 | --0 | ---- | ---- | ---768K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 92.85%10.54M | 22.35%-4.65M | -128.98%-12.64M | 47.55%-19.64M | 29.26%-13.61M | 270.20%5.47M | 14.46%-5.98M | 31.12%-5.52M | ---37.45M | ---19.23M |
| Net cash flow | ||||||||||
| Beginning cash position | -150.08%-1.18M | -52.36%5.91M | 21.36%34.02M | -12.18%28.03M | 16.18%5.33M | -48.59%2.35M | -11.15%12.41M | -12.18%28.03M | --31.92M | --4.59M |
| Current changes in cash | 192.77%8.71M | 29.49%-7.09M | -79.95%-28.11M | 254.01%5.99M | 22.37%28.69M | 42,385.71%2.97M | -7.10%-10.06M | 12.98%-15.62M | ---3.89M | --23.45M |
| End cash Position | 41.29%7.53M | -150.08%-1.18M | -52.36%5.91M | 21.36%34.02M | 21.36%34.02M | 16.18%5.33M | -48.59%2.35M | -11.15%12.41M | --28.03M | --28.03M |
| Free cash from | 26.46%-1.83M | 39.97%-2.45M | -53.17%-15.47M | -24.31%25.63M | -0.89%42.3M | -177.41%-2.49M | -69.92%-4.08M | -4.80%-10.1M | --33.86M | --42.68M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.